#JustPublished!
Threat Assessment Brief: Implications for the EU/EEA of the spread of the #SARSCoV2 #Omicron XBB.1.5 sub-lineage.
Overall level of risk is low for the EU/EEA general population; moderate to high for vulnerable individuals.
Read:
https://bit.ly/XBB15TAB
#COVID19
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1613904638176120834
Mathematical modelling indicates that #XBB15 could become dominant in the EU/EEA after 1-2 months, given the current low proportions reported in the EU/EEA & its estimated growth rate.
No signals of increased severity of XBB.1.5 compared to circulating omicron sub-lineages.
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1613904641015652352
#XBB15 is a sub-lineage of #XBB, which evolved from two earlier lineages of #Omicron, with an additional mutation.
First detected in the US in October, has been growing in proportion in many countries around the world.
ECDC designed it as a Variant of Interest on 12.01.2023
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1613904645272772611
The proportion of XBB.1.5 in EU/EEA was lower than 2.5% for the final 2 weeks of '22 (the most recent period where variant proportions at this low level can be accurately estimated).
In the US, #XBB15 is currently spreading 12% faster than other variants.
https://bit.ly/XBB15TAB
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1613904643326705666